Previous 10 | Next 10 |
home / stock / numi:cc / numi:cc news
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical study using the Company’s unique psychedelic molecul...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effec...
Numinus Develops Mushroom Tea for Use in Psychedelic Research Canada NewsWire Psilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics VANCOUVER, B.C , Oct. 5, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus"...
Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022 Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022 Canada NewsWire VANCOUVER, BC , Sept. 29, 2022 /CNW/ - ...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 23, 2022 – Canadian health insurers processed nearly $600 million in mental health service claims in 2021, up 75% from 2019 as more Canadians tapped into their me...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminali...
Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives Canada NewsWire New Montreal space will focus on treating depression, addiction and other common disorders Numinus announces sponsorship of East F...
Numinus Now Offers Ketamine-Assisted Therapy in Toronto Canada NewsWire Treatment will be offered at the Neurology Centre of Toronto in Forest Hill VANCOUVER, BC , Sept. 19, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company")...
Numinus provides update on acquisition integration and announces new client financing options Canada NewsWire US clinics acquired from Novamind demonstrating continued growth Physical rebranding of clinics is underway Announcing new client financing o...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to 30 who repor...
News, Short Squeeze, Breakout and More Instantly...
Numinus Wellness Inc. Company Name:
NUMI:CC Stock Symbol:
TSXC Market:
Numinus Wellness Inc. Website:
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results Canada NewsWire Q3 Fiscal 2024 Highlights Revenue of $4.3 million , a 1.9% decline over Q2 2024 Gross profit of $1.0 million , a 9.8% decline over Q2 2024 Cash position of $3.7 million ...
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 Canada NewsWire VANCOUVER, BC , July 10, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing tradition...
Numinus Wellness Announces Resignation of Director Canada NewsWire VANCOUVER, BC , June 24, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional a...